Case Study: Oxford Brain Diagnostics positions itself for growth with Brands2Life

Oxford Brain Diagnostics positions for Series A investment with Brands2Life

Oxford Brain Diagnostics, a University of Oxford spin-out, needed to define its market purpose and position itself to a wide variety of audiences, including investors, clinicians, and the pharma industry, in order to scale its business. Brands2Life was engaged to help the company establish a clear narrative to support its Series A funding goals and drive future clinical acceptance.

Brands2Life implemented an audience-centric approach involving in-depth research and stakeholder interviews. This process led to the development of a new mission statement, "Rethinking Brain Health," and a full suite of core and audience-specific messaging. The new positioning successfully helped secure a substantial investment from a key customer for clinical testing and is being used to build proposals for Series A funding.

Oxford Brain Diagnostics